Abstract Changes in the biomechanical properties of the human cornea play an important
role in the pathogenesis of corneal ectatic diseases. Biomechanical investigation shows …

Since its inception in the late 1990s, corneal cross-linking has grown from an interesting
concept to a primary treatment for corneal ectatic disease worldwide. Using a combination of …

PURPOSE: To test the biomechanical efficiency of corneal crosslinking with riboflavin
without epithelial debridement (C3-R). SETTING: Moscow Helmholtz Research Institute of …

Purpose: To evaluate the clinical effects of transepithelial corneal cross-linking (CXL) on
keratoconic eyes pre-treated with substances enhancing epithelial permeability. Methods …

PURPOSE: To evaluate intrastromal concentrations of riboflavin with and without epithelium
to ensure the efficacy and safety of corneal crosslinking (CXL) by the standard and …

Objectives To report intraoperative and 24-month refractive, topographic, tomographic, and
aberrometric outcomes after corneal collagen cross-linking in progressive advanced …

Background Keratoconus is a condition of the eye that affects approximately 1 in 2000
people. The disease leads to a gradual increase in corneal curvature and decrease in visual …

Corneal ectasia is a progressive, degenerative, and noninflammatory thinning disorder of
the cornea. Recently developed corneal resha** techniques have expanded the treatment …

Purpose To review cross‐linking the cornea using riboflavin and ultraviolet A light, which
has been widely adopted, refined and applied in a range of corneal surgeries and …

PURPOSE: To evaluate the effect of benzalkonium chloride–assisted (BAC) transepithelial
collagen crosslinking (CXL) in eyes with progressive keratoconus and a minimum follow-up …